| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |